Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATER: Clopidogrel Effects on CRP in CAD
NCT00343876Phase 4Completed
- Sponsor
- Intermountain Health
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by Intermountain Health. Started Jul 2005; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00343876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343876.